← FDA Drug Approvals (Drugs@FDA)

JUVMO

NDA · New Drug Application · Sponsor: ABBVIE INC · Approved 2026-09-25

Drug application

FDA Application #

NDA220415

Application type

New Drug Application

Brand name

JUVMO

Generic name

Tavapadon

Active ingredients

TAVAPADON

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ABBVIE INC

First approval

2026-09-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown